press_release_conclusion: Aspirin cuts cancer rates in people with hereditary risk by more than half
abstract_conclusion: 600 mg aspirin per day for a mean of 25 months substantially reduced cancer incidence after 55·7 months in carriers of hereditary colorectal cancer.